Sanofi logo

Sanofi dividend yield (ttm)NASDAQ: SNY

Annual

Dividend yield (TTM)

3.84%
+0.03%+0.79%

01 November 2024

-47.03%vs 3 years high
+611.11%vs 3 years low
77.78%vs. sector
Performance
Most recent+0.8%
1 year-6.3%
3 years+2.1%
5 years+0.8%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend yield (TTM) performance

Most recent change
SNY+0.8%
SYK-3.3%
BSX-
VRTX-
MDT-2.2%
GILD-1.4%
BMY+1.9%
1 year change
SNY-6.3%
SYK-20.9%
BSX-
VRTX-
MDT-21.2%
GILD-8.1%
BMY-1.1%
3 years change
SNY+2.1%
SYK-7.5%
BSX-
VRTX-
MDT+51.7%
GILD-20.1%
BMY+31.7%
5 years change
SNY+0.8%
SYK-11.2%
BSX-
VRTX-
MDT+58.9%
GILD-10.0%
BMY+53.3%

Dividend yield (TTM) performance

SNYSYKBSXVRTXMDTGILDBMY
Most recent+0.8%-3.3%---2.2%-1.4%+1.9%
1 year-6.3%-20.9%---21.2%-8.1%-1.1%
3 years+2.1%-7.5%--+51.7%-20.1%+31.7%
5 years+0.8%-11.2%--+58.9%-10.0%+53.3%
FAQ

What is Sanofi dividend yield (ttm)?

Sanofi dividend yield (ttm) is 3.84%

What is Sanofi dividend yield (ttm) compared to its 3-years maximum value?

Sanofi dividend yield (ttm) is 52.97% of its 3-years maximum value

What is Sanofi dividend yield (ttm) compared to other companies from its sector (Healthcare)?

Sanofi dividend yield (ttm) is higher than 77.78% of the companies in the same sector (Healthcare)

How has Sanofi dividend yield (ttm) changed over the year?

Over the past year, Sanofi dividend yield (ttm) has dropped by 6.3%. During the same period, Stryker has dropped by 20.9%, Medtronic has dropped by 21.2%, Gilead Sciences has decreased by 8.1%, Bristol-Myers Squibb has gone down by 1.1%

How has Sanofi dividend yield (ttm) changed over the 3 years?

During the last 3 years, Sanofi dividend yield (ttm) has increased by 2.1%. Over the same period, Stryker has dropped by 7.5%, Medtronic has increased by 51.7%, Gilead Sciences has decreased by 20.1%, Bristol-Myers Squibb has grown by 31.7%

How has Sanofi dividend yield (ttm) changed over the 5 years?

For the past 5 years, Sanofi dividend yield (ttm) has increased by 0.8%. In the same period, Stryker has dropped by 11.2%, Medtronic has increased by 58.9%, Gilead Sciences has decreased by 10.0%, Bristol-Myers Squibb has grown by 53.3%